Randomized, Placebo-controlled, Parallel-group Study in Healthy Male Subjects to Investigate the Pharmacodynamics During the Switching Procedure From Warfarin to Rivaroxaban.
Phase of Trial: Phase I
Latest Information Update: 02 Jul 2014
At a glance
- Drugs Rivaroxaban (Primary) ; Vitamin K; Warfarin
- Indications Venous thrombosis
- Focus Pharmacodynamics; Pharmacogenomic
- Sponsors Bayer
- 10 Jun 2017 Biomarkers information updated
- 17 Feb 2014 Results published in the British Journal of Clinical Pharmacology.
- 17 Jan 2012 New trial record